| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3164315 | Oral Oncology | 2014 | 6 Pages |
Abstract
SummaryObjectivesAlthough widely adopted, the accuracy of post-chemoradiotherapy (CRT) 18F-fluorodeoxygluocose positron emission tomography/computed tomography (PET/CT) for predicting locoregional failure (LRF) in human papillomavirus-related (HPV+) oropharyngeal cancer (OPC) remains poorly characterized. We assessed the predictive value of 3-month PET/CT response for LRF in this population.Materials and methods101 consecutive patients with stage III-IV HPV+ OPC who underwent definitive CRT with pre-treatment and 3-month post-CRT PET/CT at our institution from 3/2005-3/2011 were included. 3-month PET/CT response was re-classified as complete-response (CR), near-CR, or incomplete-response (
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Jeffrey M. Vainshtein, Matthew E. Spector, Matthew H. Stenmark, Carol R. Bradford, Gregory T. Wolf, Francis P. Worden, Douglas B. Chepeha, Jonathan B. McHugh, Thomas Carey, Ka Kit Wong, Avraham Eisbruch,